Aralez Pharmaceuticals announced its U.S. commercial launch of vorapaxar, an PAR-1 inhibiting antiplatelet therapy, for the reduction of thrombotic CV events. Vorapaxar (Zontivity, Aralez) is ...
The S&P TSX Composite Index is the main indicator for the Canadian stock market, akin to the S&P 500 in the U.S. It’s a measure of the stock market’s health. If someone says “Canadian stocks were up ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results